Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H18N2O3 |
| Molecular Weight | 262.3043 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12OCC[C@@]1(C)C3=CC(OC(=O)NC)=CC=C3N2C
InChI
InChIKey=LXTKNVLLWOLCOV-JSGCOSHPSA-N
InChI=1S/C14H18N2O3/c1-14-6-7-18-12(14)16(3)11-5-4-9(8-10(11)14)19-13(17)15-2/h4-5,8,12H,6-7H2,1-3H3,(H,15,17)/t12-,14-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Efficient formal total synthesis of physostigmine and physovenine: conformational analysis of key intermediates. | 2002 Feb |
|
| Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. | 2005 Feb 24 |
|
| An interrupted Fischer indolization approach toward fused indoline-containing natural products. | 2009 Aug 6 |
|
| Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. | 2009 Jan 1 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
442113
Created by
admin on Sat Dec 16 08:02:31 GMT 2023 , Edited by admin on Sat Dec 16 08:02:31 GMT 2023
|
PRIMARY | |||
|
H67Q5553UW
Created by
admin on Sat Dec 16 08:02:31 GMT 2023 , Edited by admin on Sat Dec 16 08:02:31 GMT 2023
|
PRIMARY | |||
|
DTXSID90877566
Created by
admin on Sat Dec 16 08:02:31 GMT 2023 , Edited by admin on Sat Dec 16 08:02:31 GMT 2023
|
PRIMARY | |||
|
m8767
Created by
admin on Sat Dec 16 08:02:31 GMT 2023 , Edited by admin on Sat Dec 16 08:02:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
6091-05-0
Created by
admin on Sat Dec 16 08:02:31 GMT 2023 , Edited by admin on Sat Dec 16 08:02:31 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
